Article Versions Notes

Nicoud MB, Ospital IA, Táquez Delgado MA, Riedel J, Fuentes P, Bernabeu E, Rubinstein MR, Lauretta P, Martínez Vivot R, Aguilar MdlÁ, et al. Nanomicellar Formulations Loaded with Histamine and Paclitaxel as a New Strategy to Improve Chemotherapy for Breast Cancer. International Journal of Molecular Sciences. 2023; 24(4):3546. https://doi.org/10.3390/ijms24043546

Nicoud, Melisa B., Ignacio A. Ospital, Mónica A. Táquez Delgado, Jennifer Riedel, Pedro Fuentes, Ezequiel Bernabeu, Mara R. Rubinstein, Paolo Lauretta, Rocío Martínez Vivot, María de los Ángeles Aguilar, and et al. 2023. "Nanomicellar Formulations Loaded with Histamine and Paclitaxel as a New Strategy to Improve Chemotherapy for Breast Cancer" International Journal of Molecular Sciences 24, no. 4: 3546. https://doi.org/10.3390/ijms24043546

Nicoud, M. B., Ospital, I. A., Táquez Delgado, M. A., Riedel, J., Fuentes, P., Bernabeu, E., Rubinstein, M. R., Lauretta, P., Martínez Vivot, R., Aguilar, M. d. l. Á., Salgueiro, M. J., Speisky, D., Moretton, M. A., Chiappetta, D. A., & Medina, V. A. (2023). Nanomicellar Formulations Loaded with Histamine and Paclitaxel as a New Strategy to Improve Chemotherapy for Breast Cancer. International Journal of Molecular Sciences, 24(4), 3546. https://doi.org/10.3390/ijms24043546